NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
59 hedge funds and large institutions have $533M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 32 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
+8
Holders Change %
+15.69%
% of All Funds
1.17%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
13
Increased
32
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
$42.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$8.5M |
| 3 |
JPMorgan Chase & Co
New York
|
$5.27M |
| 4 |
PS
Peter Svennilson
|
$304M |
| 5 |
State Street
Boston,
Massachusetts
|
$6.97M |
